Skip to main content
Equibles

Propel Bio Management, LLC

Position in IMUX — Immunic, Inc.

CIK 1969764 LOS ANGELES, CA
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,995,588
+$2,392,884 QoQ
Shares Held
325,022
+38.6% QoQ
Ownership
2.38%
of shares outstanding
% of Portfolio
2.61%
of 13F equity value
Holder Rank
#11
of 55 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 91% Shared 9% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Propel Bio Management, LLC holds $132,912,353 across 24 Biotechnology names. IMUX ranks #9 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ACHV
Achieve Life Sciences, Inc.
 4,034,018 $26,342,137
2 CORT
Corcept Therapeutics Inc
 136,499 $11,868,588
3 PHAT
Phathom Pharmaceuticals, Inc.
 1,050,358 $11,396,384
4 MIST
Milestone Pharmaceuticals Inc.
 7,429,590 $9,955,650
5 KYTX
Kyverna Therapeutics, Inc.
 883,198 $7,869,294
6 ARTV
Artiva Biotherapeutics, Inc.
 696,436 $6,755,429
7 ABEO
Abeona Therapeutics Inc.
 983,070 $6,075,372
8 PALI
Palisade Bio, Inc.
 2,582,388 $5,397,190

All Filings in IMUX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,995,588 325,022
2026-03-31 $2,602,704 2,344,779